Search

everythinglearnresearchcommunity

for

Search:↓

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

A specific gene change is linked to severe hair loss.

The 308-nm excimer laser helps hair regrowth in some alopecia areata cases but not all.

Most children treated with diphencyprone regrew some or all of their hair.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

The 308-nm Excimer laser is effective and safe for treating patchy alopecia areata in children.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Minoxidil can help regrow hair in alopecia areata patients.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

CD44 variant changes start alopecia areata, but don't maintain it.

Alopecia areata and its severe forms are becoming more common, especially among females, adults, and people in the Northeast.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Etanercept may not prevent alopecia areata from coming back.

Both steroids effectively promote hair growth for at least 9 months.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Minoxidil and finasteride treat hair loss; more research needed for other options.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Vitiligo and alopecia areata may have similar causes despite their differences.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Stress might contribute to hair loss in alopecia areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Adalimumab may cause severe hair loss in some patients.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.